Mitchell Haut, MD

Mercy Cancer Center at Mercy ...Canton, Ohio - 44708 (330-453-9993) |
- CLINICAL TRIALS 27
- CONDITIONS35
- INTERVENTIONS60
- SINCE1991

Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
June 2008 - December 2009

Adjuvant Doxorubicin Cyclophosphamide and Paclitaxel in Treating Patients With Breast Cancer
November 2003 - June 2012

Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
June 2007 - April 2012

Zoledronate Vitamin D and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer Lung Cancer or Breast Cancer
July 2006 - March 2013

Bevacizumab and Paclitaxel Paclitaxel Albumin-Stabilized Nanoparticle Formulation or Ixabepilone in Treating Patients With Stage IIIC or Stage IV Breast Cancer
October 2008 - October 2010

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
August 2008 - August 2013

Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
April 2009 - April 2010

Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer
March 2009 - January 2014

Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II Stage III or Stage IV Ovarian Epithelial Cancer Fallopian Tube Cancer or Primary Peritoneal Cancer
August 2009 - January 2016

Melphalan Prednisone and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
February 2008 - August 2009

Paclitaxel Cisplatin and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
June 2008 - December 2015

Doxorubicin Cyclophosphamide and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk Lymph Node-Negative Breast Cancer
November 2007 - November 2013

Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I Stage II or Stage III Non-Small Cell Lung Cancer
October 2005 - February 2008

Paclitaxel Carboplatin and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
March 2010 - December 2010

Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
November 2005 - June 2008

Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers
July 1991 -

Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
July 2005 - July 2012

Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
April 1999 -

Bevacizumab Sorafenib and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
September 2007 - May 2012

Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer
July 2009 - December 2010

Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
July 2004 -

Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
June 2007 - January 2010

Carboplatin and Paclitaxel Combined With Cetuximab and/or Cixutumumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
September 2009 - January 2011

Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
July 2009 - August 2011

Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
March 2010 - January 2020

Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB Stage II or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
June 2007 - July 2015

Carboplatin Paclitaxel and Bevacizumab With or Without Erlotinib Hydrochloride in Treating Non-Smokers With Advanced Non-Small Cell Lung Cancer
January 2010 - July 2012
Breast Neoplasms
Colonic Neoplasms
Lung Neoplasms
Nervous System Neoplasms
Central Nervous System Neoplasms
Lymphoma
Adenocarcinoma
Prostatic Neoplasms
Multiple Myeloma
Neoplasms, Plasma Cell
Leukemia
Neoplasms
Neoplasm Metastasis
Myelodysplastic Syndromes
Preleukemia
Ovarian Neoplasms
Urinary Bladder Neoplasms
Carcinoma, Renal Cell
Kidney Neoplasms
Head and Neck Neoplasms
Carcinoma, Non-Small-Cell Lung
Esophageal Diseases
Esophageal Neoplasms
Peritoneal Neoplasms
Fallopian Tube Neoplasms
Glioblastoma
Carcinoma, Small Cell
Precancerous Conditions
Myeloproliferative Disorders
Colorectal Neoplasms
Carcinoma, Transitional Cell
Hematologic Neoplasms
Ureteral Neoplasms
Urologic Neoplasms
Urethral Neoplasms
Placebo
Melphalan
Immunohistochemistry Staining Method
Laboratory Biomarker Analysis
Zoledronic Acid
Study Of Socioeconomic And Demographic Variables
Paclitaxel
Carboplatin
Bevacizumab
Cisplatin
Docetaxel
Fluorouracil
Leucovorin Calcium
Erlotinib Hydrochloride
Gemcitabine Hydrochloride
Gene Expression Analysis
Polymorphism Analysis
Cyclophosphamide
Prednisone
Radiation Therapy
Lenalidomide
Pemetrexed Disodium
Temozolomide
Oxaliplatin
Doxorubicin Hydrochloride
Temsirolimus
Polymerase Chain Reaction
Sunitinib Malate
Vitamin D
Trastuzumab
Cixutumumab
Sorafenib Tosylate
Thalidomide
Fluorescence In Situ Hybridization
Rosuvastatin
Mutation Analysis
Cetuximab
Biologic Sample Preservation Procedure
Study Of High Risk Factors
Matrix-Assisted Laser Desorption/Ionization Time Of Flight Mass Spectrometry
Calcium Carbonate
Irinotecan Hydrochloride
Etoposide Phosphate
Ixabepilone
Paclitaxel Albumin-Stabilized Nanoparticle Formulation
Ac Regimen
Cytogenetic Analysis
Therapeutic Thoracoscopy
Videothoracoscopy
Hedgehog Antagonist Gdc-0449
Calcium Citrate
Calcium Glucarate
Calcium Gluconate
Samarium Sm 153 Lexidronam Pentasodium
Strontium Chloride Sr 89
Vinorelbine Ditartrate
Standard Follow-Up Care
Placebo Administration
Chromogenic In Situ Hybridization
Fluorescent Antibody Technique



